Skip to content

StagingTesting mode — staging environment. No real money: balances, trades, and accounts are for testing only and may be reset at any time.DEMODemo mode: simulated data, for showcase only

Trending New All Live Politics Sports Culture Crypto Economics Companies Climate Tech & Science World Media

Trending New All

Live Politics Sports Culture Crypto Economics Companies Climate Tech & Science World Media

Wegovy revenue tops $10B in 2026? | Drazill

Tech & Science·Health & Biotech

Wegovy revenue tops $10B in 2026?

Wegovy revenue tops $10B in 2026?

Price and outcomes

Wegovy revenue tops $10B in 2026?

44¢44¢

56¢56¢

About This Market

Wegovy, including the new HD 7.2 mg dose, anchors Novo's obesity sales. Resolves YES if Novo reports full-year 2026 Wegovy revenue above DKK-equivalent US$10 billion. Source: Novo Nordisk annual report.

Activity and discussion

Holders

Wegovy revenue tops $10B in 2026?

Amount

Related Markets

FDA approves Novo's CagriSema in 2026?

FDA approves Novo's CagriSema in 2026?

GLP-1 obesity market leader end of 2026?

GLP-1 obesity market leader end of 2026?

WHO declares an H5N1 pandemic in 2026?

WHO declares an H5N1 pandemic in 2026?